Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer

导出原文传递学术成果认领

作者单位 College of Pharmacy, Nanchang University, Nanchang 330006, China;Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China ^[1] Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China ^[2]

关键词 thyroid cancer AL3810 multi-tyrosine kinases inhibitor angiogenesis RET

栏目名称 Chemotherapy

DOI 10.1038/aps.2017.107

发布时间 2017-11-30

基金项目

the Personalized Medicines-Molecular Signature-based Drug Discovery and Development,Strategic Priority Research Program of the Chinese Academy of Sciences grants from the National Natural Science Foundation of China

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2
被引0
下载0

中国药理学报（英文版）

2017年38卷11期

1533-1542页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除